EAS populations harbor both high-frequency ACE2-hg1 (43%) and ACE2-hg2 (53%), indicating differentiation of COVID-19 severities, i.e. the majority will have a lower risk of severe COVID-19, but another half will have a higher risk. This evidence concerns the gene ACE2 and COVID-19.